ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GSK Gsk Plc

1,647.50
11.50 (0.70%)
Last Updated: 14:04:46
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  11.50 0.70% 1,647.50 1,647.50 1,648.00 1,656.00 1,635.00 1,642.00 1,911,153 14:04:46
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.78 67.89B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,636p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £67.89 billion. Gsk has a price to earnings ratio (PE ratio) of 13.78.

Gsk Share Discussion Threads

Showing 30801 to 30823 of 33100 messages
Chat Pages: Latest  1240  1239  1238  1237  1236  1235  1234  1233  1232  1231  1230  1229  Older
DateSubjectAuthorDiscuss
16/8/2022
20:05
The plaintiff in the first Zantac case appears to have voluntarily dismissed the case without settlement according to news wires
daneswooddynamo
16/8/2022
13:51
You wouldn't need a penny for halfpenny's thoughts......we all get them for free.How lucky are we?
redbaron10
16/8/2022
12:35
So you are not worth even a penny!
abdullla
16/8/2022
12:32
just filter him..
lippy4
16/8/2022
12:29
Change the record pal
alibizzle
16/8/2022
12:07
GSK are a very high risk. Its only greed that keeps many holding onto GSK. Its therefore important that many are aware of the Risks and avoid the hype its a good investment at this time of many Cancer Claims. So dont fall into any traps as MM’s will sell before you do. Q. Do you feel lucky???
halfpenny
16/8/2022
11:45
Halfpenny I'm not sure what you have against GSK and the joy you are taking from seeing investors lose money , but please stop as you are t helping anyone and it's pretty pathetic tbf
alibizzle
16/8/2022
11:24
halfpenny16 Aug '22 - 11:19 - 30609 of 30609 (filtered)
tradermichael
16/8/2022
11:24
court case story has run out of steam.
People are vaguely beginning to think in terms of recovery back to 1500, 1700 and 2200

netcurtains
16/8/2022
11:19
GSK don't be fooled as plenty of falls in the pipeline as Claims increase. Too Risky at this level the risk reward is low. Lawyers are ramping up claimants and getting ready for their Xmas bonuses. I see this as a small Cat bounce or is it a Kitten Bounce with huge falls to come soon. 800 or less is very feasible at this Risky stage..
halfpenny
16/8/2022
10:22
fair play one and all. luck to you as well.
unastubbs
16/8/2022
10:05
I need £17 to break even but tbh happy to sit on a loss for 2-3 years and collect dividends if need be
alibizzle
16/8/2022
10:04
About 2200 for me.
Not sure.
Who cares?

Break even is not a thing,
I always say it is where you are now that counts, not the past - that is been and gone.

GSK appears to be going up.
And that is good!

netcurtains
16/8/2022
09:50
High £15's for me right now.
A few days of gains north of 20p and I may top up / average down. That would give me confidence that £14 is the low.

tuftymatt
16/8/2022
09:43
what's your break even btw?
unastubbs
16/8/2022
09:40
dont be late
netcurtains
16/8/2022
09:30
woke appointment. gwgb.
unastubbs
16/8/2022
09:11
Substitute Walmsley full stop.
tradermichael
16/8/2022
08:39
Good to see GSK bounce back today.
I am a bit worried about the Elliott position (among other things!!).
News in the FT today that Elliott has exited its $2.5en investment in SoftBank after losing faith that the CEO could turn it around.
The shares were acquired in 2020, Elliott are thought to have sold some in 2021 at a good profit and then unloaded the rest earlier this year as the share price fell back.
Substitute GSK for SoftBank and Walmsley for Maysayoshi Son and the story could be otherwise identical.

spyder
16/8/2022
08:13
From todays announcement:
"
Tony Wood, Chief Scientific Officer, GSK , said: "Affinivax's exciting pneumococcal vaccine candidates, the potentially disruptive MAPs technology and their fantastic scientific talent, further strengthen our pipeline of novel vaccines and presence in the Boston area".
"

netcurtains
16/8/2022
08:06
Let's start as we mean to go on 👍🏻
tuftymatt
16/8/2022
01:17
free stock charts from uk.advfn.com
buywell3
15/8/2022
22:06
No professional company would release confidential information. So looks like it is just fake
maxplus2
Chat Pages: Latest  1240  1239  1238  1237  1236  1235  1234  1233  1232  1231  1230  1229  Older

Your Recent History

Delayed Upgrade Clock